Fabiflu is for mild to moderate cases of COVID-19. Covifor and Cipremi Covifor and Cipremi are versions of USFDA-approved Remdesivir.
indica News Bureau- Gilead Sciences, the US drug maker has signed a non-exclusive voluntary licensing agreements with three Indian pharmaceutical companies — Hyderabad-based Hetero Labs, Mumbai-headquartered Cipla, and Noida-based Jubilant Life Sciences to manufacture and sell the anti-viral drug to people who have severe COVID-19 infection. US-based Mylan which has a strong base in India […]
An Indian-American researcher in the US has identified 4 antiviral drugs which also includes remdesivir which can be effective in preventing the replication of the novel coronavirus disease which causes COVID-19. It can be noted that Remdesivir was originally developed to treat Ebola. Kamlendra Singh and his team used a computer aided drug design to […]
indica News Bureau- Gilead Sciences Inc.’s antiviral drug remdesivir was cleared by U.S. regulators for emergency use in Covid-19 patients, becoming the first medication backed by early clinical data to be made available to fight the novel coronavirus. Remdesivir reduced the time it took hospitalized Covid-19 patients to recover in an interim analysis of an […]
Ritu Jha- It seems malaria drug hydroxychloroquine has been overtaken by the new up and coming drug Remdesivir that is considered as the first effective coronavirus treatment, according to the US top infectious disease expert. Developed by Gilead Sciences Inc., an American biopharmaceutical company based in Foster City, California, Remdesivir has been going through its […]
Ritu Jha- It was mid-January when Dr. Prasun Mishra, founder of the American Association for Precision Medicine (AAPM), was on a call with his friend Jay Chen, who was visiting China to celebrate Chinese New Year. There was a word of a new virus sickening a small population in Wuhan, and some physicians thought it […]